<p>Xvivo Perfusion AB has postponed the publication of its interim report for the period January-March 2026. The report, initially scheduled for release on April 22, 2026, will now be published on April 24, 2026. The delay is due to the company’s presentation of its U.S. heart preservation study at the ISHLT conference in Toronto. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xvivo Perfusion AB published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1135533) on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

562600

159883

512170

159898

Reuters

ChinaAMC CSI All Share Health Care Devices ETF

SPDR S&P Health Equip

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

Health Care Select Sector SPDR

iShares US Medical Devices

Hwabao WP CSI Medical Service ETF

China Merchants CSI All Share Medical Apparatus and Instruments ETF

Xvivo Perfusion AB Delays Q1 2026 Interim Report Release